ArticleEmerging microbes & infections2021

A human cell-based SARS-CoV-2 vaccine elicits potent neutralizing antibody responses and protects mice from SARS-CoV-2 challenge.

Xiangchuan He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.